Epidermal Growth Factor Receptor (EGFR) is classically known for its implications in the etiology of diverse cancers by regulating cell division, differentiation and death. However, the ability of the oncogenic receptor to interact with several cellular intermediates, modulate signaling events and alter gene expression is also tapped by infectious agents to drive their pathogenesis. There is a wide array of nodes where pathogens intersect with EGFR signaling ranging from host cell adhesion/entry to phagosomal maturation and inflammation. Therefore, the understanding of these mechanisms would offer effective EGFR-directed therapeutic/vaccination strategies against the rising incidence of antibiotic-resistant infections.